Graybill Bartz & Assoc LTD Thermo Fisher Scientific Inc. Transaction History

Graybill Bartz & Assoc LTD

  • $249 Million
  • Q3 2024

A detailed history of Graybill Bartz & Assoc LTD transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Graybill Bartz & Assoc LTD holds 12,506 shares of TMO stock, worth $6.55 Million. This represents 3.11% of its overall portfolio holdings.

Number of Shares
12,506
Previous 12,283 1.82%
Holding current value
$6.55 Million
Previous $6.79 Million 13.88%
% of portfolio
3.11%
Previous 2.86%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024
BUY
$531.86 - $624.21 $118,604 - $139,198
223 Added 1.82%
12,506 $7.74 Million
Q2 2024

Jul 22, 2024
BUY
$541.52 - $599.02 $17,328 - $19,168
32 Added 0.26%
12,283 $6.79 Million
Q1 2024

Apr 15, 2024
BUY
$528.82 - $599.43 $67,160 - $76,127
127 Added 1.05%
12,251 $7.12 Million
Q4 2023

Feb 08, 2024
SELL
$431.41 - $532.94 $101,381 - $125,240
-235 Reduced 1.9%
12,124 $6.44 Million
Q3 2023

Nov 03, 2023
SELL
$498.29 - $574.41 $22,423 - $25,848
-45 Reduced 0.36%
12,359 $6.26 Million
Q2 2023

Jul 21, 2023
BUY
$508.46 - $591.13 $282,195 - $328,077
555 Added 4.68%
12,404 $6.47 Million
Q1 2023

Apr 27, 2023
SELL
$535.0 - $604.82 $57,780 - $65,320
-108 Reduced 0.9%
11,849 $6.83 Million
Q4 2022

Jan 23, 2023
BUY
$484.71 - $571.37 $86,278 - $101,703
178 Added 1.51%
11,957 $0
Q3 2022

Oct 28, 2022
SELL
$507.19 - $604.49 $102,452 - $122,106
-202 Reduced 1.69%
11,779 $5.97 Million
Q2 2022

Jul 29, 2022
SELL
$500.9 - $612.21 $142,255 - $173,867
-284 Reduced 2.32%
11,981 $6.51 Million
Q1 2022

May 12, 2022
BUY
$524.0 - $644.92 $174,492 - $214,758
333 Added 2.79%
12,265 $7.24 Million
Q4 2021

Jan 28, 2022
SELL
$569.0 - $667.24 $1.32 Million - $1.55 Million
-2,319 Reduced 16.27%
11,932 $7.96 Million
Q3 2021

Oct 22, 2021
SELL
$509.53 - $609.78 $154,897 - $185,373
-304 Reduced 2.09%
14,251 $8.14 Million
Q2 2021

Jul 27, 2021
BUY
$441.0 - $508.24 $94,374 - $108,763
214 Added 1.49%
14,555 $7.34 Million
Q1 2021

Apr 19, 2021
BUY
$439.85 - $518.83 $26,391 - $31,129
60 Added 0.42%
14,341 $6.55 Million
Q4 2020

Jan 20, 2021
SELL
$435.06 - $527.66 $61,778 - $74,927
-142 Reduced 0.98%
14,281 $6.65 Million
Q3 2020

Oct 19, 2020
SELL
$359.77 - $441.52 $42,093 - $51,657
-117 Reduced 0.8%
14,423 $6.37 Million
Q2 2020

Jul 20, 2020
SELL
$275.2 - $362.34 $148,057 - $194,938
-538 Reduced 3.57%
14,540 $5.27 Million
Q1 2020

Apr 30, 2020
SELL
$255.3 - $340.05 $75,824 - $100,994
-297 Reduced 1.93%
15,078 $4.28 Million
Q4 2019

Jan 24, 2020
SELL
$271.93 - $328.04 $116,657 - $140,729
-429 Reduced 2.71%
15,375 $5 Million
Q3 2019

Oct 24, 2019
SELL
$268.46 - $305.43 $52,886 - $60,169
-197 Reduced 1.23%
15,804 $4.6 Million
Q2 2019

Jul 25, 2019
BUY
$257.51 - $295.55 $17,768 - $20,392
69 Added 0.43%
16,001 $4.7 Million
Q1 2019

Apr 24, 2019
SELL
$212.17 - $273.72 $86,141 - $111,130
-406 Reduced 2.49%
15,932 $4.36 Million
Q4 2018

Feb 06, 2019
BUY
$208.47 - $251.98 $121,954 - $147,408
585 Added 3.71%
16,338 $3.66 Million
Q3 2018

Oct 12, 2018
SELL
$205.57 - $244.32 $35,974 - $42,756
-175 Reduced 1.1%
15,753 $3.85 Million
Q2 2018

Jul 23, 2018
SELL
$203.14 - $219.53 $96,085 - $103,837
-473 Reduced 2.88%
15,928 $3.3 Million
Q1 2018

Apr 18, 2018
SELL
$192.98 - $224.11 $74,297 - $86,282
-385 Reduced 2.29%
16,401 $3.39 Million
Q4 2017

Jan 16, 2018
SELL
$182.03 - $200.37 $683,886 - $752,790
-3,757 Reduced 18.29%
16,786 $3.19 Million
Q3 2017

Oct 18, 2017
BUY
$171.74 - $194.04 $3.53 Million - $3.99 Million
20,543
20,543 $3.89 Million

Others Institutions Holding TMO

# of Institutions
2,835
Shares Held
333M
Call Options Held
2.37M
Put Options Held
2.75M
View Full List

About THERMO FISHER SCIENTIFIC INC.

TMO Quotes by TradingView
  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $205B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Graybill Bartz & Assoc LTD Portfolio

Follow Graybill Bartz & Assoc LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graybill Bartz & Assoc LTD, based on Form 13F filings with the SEC.

News

Stay updated on Graybill Bartz & Assoc LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email